About us?

We are an interdisciplinary group of physicians, epidemiologists, economists and strategists designing and successfully implementing Market Access in Latin America

Learn more about us

The pharmaceutical market in Latin America is increasingly challenging, to be successful it is necessary to understand the health systems and their interest in sustainability, the regulatory environment, the challenges and incentives of payers and the situation of patients

Our interdisciplinary team with experience in assurance, generation of tools from epidemiology, pharmacoeconomics, data analysis and administration, within the pharmaceutical sector will be your best ally

Meet our team

We will take your project to the next level of success

Camilo Castañeda-Cardona



Neurologist with 7 years of consulting experience in the generation of inputs for strategies of Market Access impact from clinical epidemiology and pharmacoeconomics. More than 40 scientific publications (index H 7). Past President of the International Society of Pharmacoeconomics and Results Research (ISPOR), Colombia chapter. Co-founder and project manager of NeuroEconomix and IdeaXplore

Pieralessandro Lasalvia



Doctor, with 5 years of experience in strategy consulting in the pharmaceutical sector and technical management of projects in health economics, evidence-based medicine and data analytics. Co-founder and technical director of Ideaxplore and NeuroEconomix. PhD candidate in clinical epidemiology from the Pontificia Universidad Javeriana in Colombia

Aug 2017

Creation of IdeaXplore

Feb 2018

Development of Smartdash, RipScan and Medinfor ends

Jan 2019

Provides consultancy to 4 pharmaceutical multinationals in the Andean Region

Nov 2020

Finishes the creation of the first 10Access online course and sells it to 2 multinational pharmaceutical companies

A bit of our history

IdeaXplore was born from the growing need in the market to design and implement strategies and tools for market access successful.

Since its birth, our company has had a strong tendency to reconcile access to products that add a lot of value to patients with the sustainability of health systems in Latin America. We have a strong focus on data analytics and digital tools to deploy our market access strategies and plans

We work for them